Blood Res.  2018 Dec;53(4):325-329. 10.5045/br.2018.53.4.325.

Effective sickle hemoglobin reduction by automated red cell exchange using Spectra Optia in three Emirati patients with sickle cell disease before allogeneic hematopoietic stem cell transplantation

• Choi SJ
• Cho H
• Eom KS
• Lee JW
• Kim Y
• Lim J

• KMID: 2429308
• DOI: http://doi.org/10.5045/br.2018.53.4.325

Abstract

No abstract available.

MeSH Terms

Anemia, Sickle Cell*
Hematopoietic Stem Cell Transplantation*
Hematopoietic Stem Cells*
Hemoglobin, Sickle*
Humans
Hemoglobin, Sickle

Figure

• 

  Fig. 1 Change of hemoglobin S (green bars) and Hct (red lines) levels of 3 SCD cases according to red cell exchange (black arrows).Abbereviations: HbS, hemoglobin S; Hct, hematocrit; SCD, sickle cell disease; RCE, red cell exchange.

Reference

1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010; 376:2018–2031. PMID: 21131035.

2. Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue. J Clin Apher. 2016; 31:149–162. PMID: 27322218.

3. Kim HC. Red cell exchange: special focus on sickle cell disease. Hematology Am Soc Hematol Educ Program. 2014; 2014:450–456. PMID: 25696893.

4. Hsieh MM, Fitzhugh CD, Weitzel RP, et al. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA. 2014; 312:48–56. PMID: 25058217.

5. Engelke DR, Hoener PA, Collins FS. Direct sequencing of enzymatically amplified human genomic DNA. Proc Natl Acad Sci U S A. 1988; 85:544–548. PMID: 3267215.

6. Fung MK, Eder AF, Spitalnik SL, Westhoff CM. Technical manual. 19th ed. Bethesda, MD: American Assnociation of Blood Banks;2017. p. 645–646.

7. Lee G, Arepally GM. Anticoagulation techniques in apheresis: from heparin to citrate and beyond. J Clin Apher. 2012; 27:117–125. PMID: 22532037.

8. Papachatzopoulou A, Kourakli A, Stavrou EF, et al. Region-specific genetic heterogeneity of HBB mutation distribution in South-Western Greece. Hemoglobin. 2010; 34:333–342. PMID: 20642331.

9. Hsieh MM, Kang EM, Fitzhugh CD, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med. 2009; 361:2309–2317. PMID: 20007560.

10. Chou ST, Liem RI, Thompson AA. Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol. 2012; 159:394–404. PMID: 23034087.

11. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med. 1990; 322:1617–1621. PMID: 2342522.

12. Chae SL, Cho HI, Kim SI. A study on the frequencies of U, Diegoa, and Kell blood group antigens and anti-Dia and anti-K in Koreans. Korean J Blood Hematol. 1988; 23:183–188.

13. Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion. 2011; 51:1732–1739. PMID: 21332724.

14. Choi R, Song J, Jung HK, et al. A case of red blood cell exchange transfsuion in a patient with hemoglobin S/β-thalassemia. Korean J Blood Transfus. 2012; 23:256–261.

15. Korea Immigration Service. Korea Immigration Service Statistics Annual Report 2016. Gwacheon, Korea: Korea Immigration Service;2017. Accessed December 28, 2017. at http://www.immigration.go.kr/HP/COM/bbs_003/ListShowData.do?strNbodCd=noti0096&strWrtNo=130&strAnsNo=A&strOrgGbnCd=104000&strRtnURL=IMM_6050&strAllOrgYn=N&strThisPage=1&strFilePath=imm/.